Related people
Emma Danks is head of our UK corporate/M&A group, co-head of our global corporate/M&A group and a member of the UK Executive Board. She is recognised as one of the UK’s leading private equity lawyers and is described by clients as bright, commercial, and solutions focused. Emma is well known for her work with private equity sponsors and their portfolio companies, having acted on a wide range of leveraged buyouts and related transactions. She also frequently advises private equity backed management teams on buyout transactions and equity plans.
Emma also has specific life sciences and healthcare experience, having acted for several generic pharmaceutical companies on both buy-side and sell-side M&A transactions, as well as PE sponsors investing in this sector.
Emma was listed in The Lawyer's Hot 100 for 2018, and in the Legal Business feature on the City's female deal stars. Her team’s buyout expertise was recently recognised when they were named Private Equity Team of the Year at the British Legal Awards.
Since 2023 | Member of the UK Executive Board, Taylor Wessing |
Since 2019 | Head of UK Corporate Group and Co-head of the International Corporate group, Taylor Wessing |
2017 - 2023 | Head of the Private Equity group, Taylor Wessing |
Since 2010 | Partner, Taylor Wessing |
2006 - 2010 | Senior Associate, Clifford Chance |
2001 - 2006 | Associate, Clifford Chance |
1999 - 2001 | Trainee, Clifford Chance |
2001 | Admitted as a lawyer, England & Wales |
1998 | CPE and LPC, College of Law, Guildford |
1996 | MA Hons Newnham College, University of Cambridge |
Private Equity Exits “A Practical Analysis", October 2011 and re-issued in 2021 |
Latest news & insights
Sedex on securing investment from LDC
by multiple authors
Advising Bridgepoint on its sale of one.network
by multiple authors
Advising United Living Group on its sale to Apollo
by multiple authors
Advising ATL Technology on its acquisition of Gyrus Medical LTD. Manufacturing Operations
by multiple authors